OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer

Biochemical and Biophysical Research Communications

Volumn 461, Issue 3, 2015, Pages 525-532

  Liu, Lei ^a   Zhang, Jing ^a   Fang, Chi ^a   Zhang, Zhenbo ^a   Feng, Youji ^a   Xi, Xiaowei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

EMT; Epithelial ovarian cancer; ERK1 2; FSH; Invasion; OCT4

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NEOPLASM; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION;

BASE SEQUENCE; FOLLICLE STIMULATING HORMONE; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, FSH; RNA, SMALL INTERFERING;

EID: 84937760492     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.04.061     Document Type: Article

References (40)

1. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000 CA Cancer J. Clin. 50 2000 7 33
2. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor, E.J. Feuer, and M.J. Thun Cancer statistics, 2005 CA Cancer J. Clin. 55 2005 10 30
3. H. Naora, and D.J. Montell Ovarian cancer metastasis: integrating insights from disparate model organisms Nat. Rev. Cancer 5 2005 355 366
4. C.T. Brekelmans Risk factors and risk reduction of breast and ovarian cancer Curr. Opin. Obstet. Gynecol. 15 2003 63 68
5. A. Venn, L. Watson, F. Bruinsma, G. Giles, and D. Healy Risk of cancer after use of fertility drugs with in-vitro fertilisation Lancet 354 1999 1586 1590
6. S. Gnagy, E.E. Ming, S.S. Devesa, P. Hartge, and A.S. Whittemore Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use Epidemiology 11 2000 102 105
7. M. Daly, and G.I. Obrams Epidemiology and risk assessment for ovarian cancer Semin. Oncol. 25 1998 255 264
8. J.H. Choi, K.C. Choi, N. Auersperg, and P.C. Leung Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells Cancer Res. 66 2006 3912 3920
9. Y.S. Schiffenbauer, G. Meir, M. Maoz, S.C. Even-Ram, R. Bar-Shavit, and M. Neeman Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin Gynecol. Oncol. 84 2002 296 302
10. J. Wang, S. Rao, J. Chu, X. Shen, D.N. Levasseur, T.W. Theunissen, and S.H. Orkin A protein interaction network for pluripotency of embryonic stem cells Nature 444 2006 364 368
11. Z. Zhang, Y. Zhu, Y. Lai, X. Wu, Z. Feng, Y. Yu, R.C. Bast Jr., X. Wan, X. Xi, and Y. Feng Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway Int. J. Oncol. 43 2013 1194 1204
12. Y. Wei, Z. Zhang, H. Liao, L. Wu, X. Wu, D. Zhou, X. Xi, Y. Zhu, and Y. Feng Nuclear estrogen receptor-mediated notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation Oncol. Rep. 27 2012 504 510
13. S.K. Kang, K.C. Choi, K.W. Cheng, P.S. Nathwani, N. Auersperg, and P.C. Leung Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium Endocrinology 141 2000 72 80
14. S.K. Kang, K.W. Cheng, P.S. Nathwani, K.C. Choi, and P.C. Leung Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth Endocrine 13 2000 297 304
15. C. Peng, N.C. Fan, M. Ligier, J. Vaananen, and P.C. Leung Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells Endocrinology 135 1994 1740 1746
16. D. Bhartiya, and J. Singh FSH-FSHR3-stem cells in ovary surface epithelium: basis for adult ovarian biology, failure,aging, and cancer Reproduction 149 2014 R35 R48
17. B.S. An, D.M. Selva, G.L. Hammond, A. Rivero-Muller, N. Rahman, and P.C. Leung Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells J. Biol. Chem. 281 2006 20817 20824
18. Y. Yang, J. Zhang, Y. Zhu, Z. Zhang, H. Sun, and Y. Feng Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway Int. J. Gynecol. Cancer 24 2014 1564 1574
19. D. Vergara, B. Merlot, J.P. Lucot, P. Collinet, D. Vinatier, I. Fournier, and M. Salzet Epithelial-mesenchymal transition in ovarian cancer Cancer Lett. 291 2010 59 66
20. A. Chudecka-Glaz, I. Rzepka-Gorska, and B. Kosmowska Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary Arch. Gynecol. Obstet. 270 2004 151 156
21. R. Halperin, M. Pansky, Z. Vaknin, S. Zehavi, I. Bukovsky, and D. Schneider Luteinizing hormone in peritoneal and ovarian cyst fluids: a predictor of ovarian carcinoma Eur. J. Obstet. Gynecol. Reprod. Biol. 110 2003 207 210
22. S. Kramer, M. Leeker, and W. Jager Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy? Int. J. Biol. Markers 13 1998 165 168
23. I. Rzepka-Gorska, A. Chudecka-Glaz, and B. Kosmowska FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary Endocr. Relat. Cancer 11 2004 315 321
24. J.C. Cheng, N. Auersperg, and P.C. Leung TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells PLoS One 7 2012 e42436
25. M. Colomiere, J. Findlay, L. Ackland, and N. Ahmed Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin Int. J. Biochem. Cell. Biol. 41 2009 1034 1045
26. M.J. Choi, K.H. Cho, S. Lee, Y.J. Bae, K.J. Jeong, S.Y. Rha, E.J. Choi, J.H. Park, J.M. Kim, J.S. Lee, G.B. Mills, and H.Y. Lee hTERT mediates norepinephrine-induced slug expression and ovarian cancer aggressiveness Oncogene 0 2014
27. S.H. Park, L.W. Cheung, A.S. Wong, and P.C. Leung Estrogen regulates snail and slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha Mol. Endocrinol. 22 2008 2085 2098
28. J.H. Choi, A.S. Wong, H.F. Huang, and P.C. Leung Gonadotropins and ovarian cancer Endocr. Rev. 28 2007 440 461
29. M.T. Lau, A.S. Wong, and P.C. Leung Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells Endocrinology 151 2010 2985 2993
30. S. Yoon, and R. Seger The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions Growth Factors 24 2006 21 44
31. S. Grant, L. Qiao, and P. Dent Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival Front. Biosci. 7 2002 d376 389
32. Z.G. Goldsmith, and D.N. Dhanasekaran G protein regulation of MAPK networks Oncogene 26 2007 3122 3142
33. K.C. Choi, S.K. Kang, C.J. Tai, N. Auersperg, and P.C. Leung Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells J. Clin. Endocrinol. Metab. 87 2002 2245 2253
34. J.H. Choi, K.C. Choi, N. Auersperg, and P.C. Leung Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells Endocr. Relat. Cancer 12 2005 407 421
35. I. Mertens-Walker, C. Bolitho, R.C. Baxter, and D.J. Marsh Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta} Endocr. Relat. Cancer 17 2010 335 349
36. S.H. Chiou, M.L. Wang, Y.T. Chou, C.J. Chen, C.F. Hong, W.J. Hsieh, H.T. Chang, Y.S. Chen, T.W. Lin, H.S. Hsu, and C.W. Wu Coexpression of Oct4 and nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation Cancer Res. 70 2010 10433 10444
37. X. Dai, J. Ge, X. Wang, X. Qian, C. Zhang, and X. Li OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion Oncol. Rep. 29 2013 155 160
38. L.L. Tsai, F.W. Hu, S.S. Lee, C.H. Yu, C.C. Yu, and Y.C. Chang Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition PLoS One 9 2014 e87207
39. E. Darai, J.Y. Scoazec, F. Walker-Combrouze, N. Mlika-Cabanne, G. Feldmann, P. Madelenat, and F. Potet Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases Hum. Pathol. 28 1997 922 928
40. K. Sawada, A.K. Mitra, A.R. Radjabi, V. Bhaskar, E.O. Kistner, M. Tretiakova, S. Jagadeeswaran, A. Montag, A. Becker, H.A. Kenny, M.E. Peter, V. Ramakrishnan, S.D. Yamada, and E. Lengyel Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target Cancer Res. 68 2008 2329 2339